References
- Elia J. Drug treatment for hyperactive children Therapeutic guidelines. Drugs 1993; 46: 863–871
- Pelham W E, Greenslade K E, Vodde-Hamilton M. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standerd methylphenidate, sustained-release methylphenidate, sustained-release dextroam-phetamine, and pemoline. Pediatrics 1990; 86: 226–237
- Lander D H, Sweeney K P, Bartenbach D E, Davis P M, Menandu KB. Evidence of lack of abuse or dependence following pemoline treatment: Results of a retrospective survey. Drug Alcohol Depend 1986; 17: 213–227
- Nehra A, Mullick F, Ishak K G, Zimmerman HJ. Pemoline-associated hepatic injury. Gastroenterology 1990; 99: 1517–1519
- Tolman K G, Freston J W, Berenson M M, Sannella JJ. Hepatotoxicity due to pemoline. Report of 2 cases. Digestion 1973; 9: 532–539
- Molina V A, Orsinger OA. Effects of Mg-pemoline on the central catecholaminergic system. Arch Int Phamacodyn Ther 1981; 251: 66–79
- Gilbert J C, Allen J M, Townsend B G, Wyllie MG. Drugs affecting the central nervous system. Effects of pemoline ant tricyclic antidepressants on nerve terminal adenosine triphosphate activities and neurotransmitter release. Neurophamacology 1978; 17: 419–421
- Collier C P, Soldin S J, Swanson JM. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Clin Pharmacokinet 1985; 10: 269–278
- Bonthala C M, West A. Pemoline induced chorea and Gilles de la Tourette's syndrome. Br J Psychiatry 1983; 143: 300–302
- Mitchell E, Mathews KL. Gilles de la Tourette's disorder associated with pemoline. Am J Psychiatry 1980; 137: 1618–1619
- McNeil JR. Accidental ingestion of pemoline. Clin Pediatr Phila 1979; 18: 761–762
- David T, Vale A. Pemoline poisoning. Arch Toxicol 1981; 48: 205–207
- Singh B K, Singh A, Chusid E. Chorea in long-term use of pemoline. Ann Neurol 1983; 13: 218
- Bachman DS. Pemoline-induced Tourette's disorder. A case report. Am J Psychiatry 1981; 138: 1116–1117
- Briscoe J G, Curry S C, Gerkin R D, Ruiz RR. Pemoline-induced choreoathetosis and rhabdomyolysis. Med Toxicol Adverse Drug Exp 1988; 3: 72–76
- Nausieda P A, Koller W C, Weiner W J, Klawans HL. Pemoline-induced chorea. Neurology 1981; 31: 356–360
- Sperling L S, Horowitz JL. Metamphaetamine-induced choreoathetosis and rhabdomyolysis. Ann Intern Med 1994; 121: 986
- Rhee K J, Albertson T E, Douglas JC. Choreoatethoid disorder associated with amphetamine-like drugs. Am J Emerg Med 1988; 6: 131–133
- Lipkin P H, Goldstein I J, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention deficit hyperactivity disorder. Arch Pediatr Adolesc Med 1994; 148: 859–861
- Sallee F R, Stiller R L, Perel J M, Everett G. Pemoline-induced abnormal involuntary movements. J Clin Psychopharmacol 1989; 9: 125–129
- Klawans H L, Weiner WJ. The pharmacology of choreatic movement disorders. Prog Neurobiol 1976; 6: 49–80
- Johansson P, Levin E, Gunne L, Ellison G. Opposite effects of a D1 and D2 agonist on oral movements in rats. Eur J Pharmacol 1987; 134: 83–88